Ann Thorac News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ann thorac. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ann Thorac Today - Breaking & Trending Today

Improving lung cancer surgery through novel computed tomography

This article from Thermo Scientific outlines how Amira software was used as a tool to perform computed tomography to improve lung cancer surgery. ....

Chao Liu , United States , Huike Gao , Emily Magee , Journal Of International Medical Research , American Cancer Society , Thermo Fisher , Thermo Fisher Amira Software , Jining Medical University , Amira Software , Sponsored Content , Thermo Fisher Scientific , Thermo Scientific , International Medical , Cancer Society , Accessed January , Thorac Cardiovasc , Ann Thorac , Int Med , Content Policy , News Medical Net , Computed Tomography , Lung Cancer ,

Roivios® announces final patient enrollment in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

ROSWELL, Ga., Dec. 4, 2023 /PRNewswire/ Roivios Ltd., a medical device company pioneering a revolutionary treatment to reduce poor surgical out. ....

Bielsko Biala , Sremska Kamenica , United States , Milovan Petrovic , Lazar Velicki , Dimitrije Jeremic , John Erbey , Institute Of Cardiovascular Diseases , Prnewswire Roivios Ltd , Institute For Cardiovascular Diseases Dedinje , Acute Kidney Injury , Juxtaflow Renal Assist Device , Cardiovascular Diseases , Prof Dr Milovan Petrovic , Prof Dr Lazar Velicki , American Heart Hospital , Cardiovascular Diseases Dedinje , Chief Executive Officer , Investigational Use Only , Chief Executive , Kidney Injury , In Hospital Mortality , Coronary Artery Bypass Graft , Percutaneous Coronary Intervention , Cardiac Surgery Database , Ann Thorac ,

Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC

Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests. ....

New York , United States , Nasserk Altorki , Hisashi Saji , Astellas Pharma , Merck Sharpe Dohme , Bristol Myers Squibb , Chugai Pharma , York Genome Center , Boehringer Ingelheim , Takeda Pharmaceutical Company , Japan Blood Products Organization , Lung Cancer Study Group , Janssen Pharmaceuticals , St Marianna University School Of Medicine , Weill Cornell Medicine , Newyork Presbyterian Hospital , North American , New York Genome Center , Fujifilm Medical , Merck Sharpe , Takeda Pharmaceutical Company Limited , Cancer Study , Ann Thorac ,

Investigational Adagrasib Delivers Positive Results in Registration-Enabling Study of Patients with KRASG12C-Mutated Advanced Non-Small Cell Lung Cancer

/PRNewswire/ Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from the. ....

United States , Alexanderi Spira , Charlesm Baum , American Society Of Clinical Oncology , Virginia Cancer Specialists Research Institute , Prnewswire Mirati Therapeutics Inc , Drug Administration , Mirati Therapeutics Inc , Exchange Commission , Access Program , Clinical Oncology , Annual Meeting , Non Small Cell , Clinical Results , Enabling Study , Blinded Independent Central Review , Virginia Cancer Specialists Research , Pooled Analysis , Mirati Therapeutics , New Drug Application , Accelerated Approval , Breakthrough Therapy Designation , Investor Event , Nervous System , Mutated Lung Cancer , Expanded Access Program ,

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer

Investegate announcements from F. Hoffmann-La Roche Ltd, CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer ....

United Kingdom , United States , Nathalie Meetz , Levi Garraway , Europe Lu , Roche Tecentriq , Sileia Urech , Loren Kalm , Anne Marie Baird , Karsten Kleine , European Lung Cancer Congress , European Commission , World Health Organization , Head Of Global Product Development , European Medicines Agency , Roche Group , Committee For Medicinal Products Human Use , Roche Group Media Relations , American Cancer Society , Medicinal Products , Human Use , Chief Medical Officer , Global Product , Lung Cancer Europe , Dow Jones Sustainability Indices , Chugai Pharmaceutical ,